These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 27215057)
21. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction]. Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637 [TBL] [Abstract][Full Text] [Related]
22. Use of phosphate binders in chronic kidney disease. Ketteler M; Biggar PH Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841 [TBL] [Abstract][Full Text] [Related]
23. Phosphate: a stealthier killer than previously thought? Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627 [TBL] [Abstract][Full Text] [Related]
24. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer? Negri AL J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415 [TBL] [Abstract][Full Text] [Related]
26. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders]. Malberti F G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662 [TBL] [Abstract][Full Text] [Related]
27. Oral phosphate binders in patients with kidney failure. Feith GW N Engl J Med; 2010 Sep; 363(10):989-90; author reply 990. PubMed ID: 20809852 [No Abstract] [Full Text] [Related]
31. Phosphate binders. Is selection determined by price? No. Fernández-Giráldez E Nefrologia; 2012; 32(2):240-4. PubMed ID: 22466265 [No Abstract] [Full Text] [Related]
32. Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada. Weir MA; Jain AK; Gomes T; Juurlink DN; Mamdani M; Li L; Garg AX Am J Kidney Dis; 2011 Feb; 57(2):357-9. PubMed ID: 21251552 [No Abstract] [Full Text] [Related]
33. Using concordance with dosing techniques to achieve phosphate control. Koester LA; Rothstein M Nephrol News Issues; 2013 Nov; 27(12):22, 24, 26-8 passim. PubMed ID: 24354233 [TBL] [Abstract][Full Text] [Related]
34. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. West SL; Swan VJ; Jamal SA Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502 [TBL] [Abstract][Full Text] [Related]